Diversified Trust CO Repligen Corp Transaction History

Diversified Trust CO

$3.93 Billion
Q3 2025

A detailed history of Diversified Trust CO transactions in Repligen Corp stock. As of the latest transaction made, Diversified Trust CO holds 12,257 shares of RGEN stock, worth $1.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,257

Previous 12,218 0.32%

Holding current value

$1.87 Million

Previous $1.52 Million 7.83%

% of portfolio

0.04%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$111.43 - $134.0 $4,345 - $5,226	39 Added 0.32%	12,257 $1.64 Million
Q2 2025 Jul 11, 2025	BUY	$108.89 - $145.23 $3,048 - $4,066	28 Added 0.23%	12,218 $1.52 Million
Q1 2025 Apr 24, 2025	SELL	$127.24 - $174.24 $6,107 - $8,363	-48 Reduced 0.39%	12,190 $1.55 Million
Q4 2024 Jan 07, 2025	BUY	$123.41 - $160.92 $218,312 - $284,667	1,769 Added 16.9%	12,238 $1.76 Million
Q3 2024 Oct 07, 2024	BUY	$119.79 - $167.35 $900,820 - $1.26 Million	7,520 Added 255.0%	10,469 $1.56 Million

Q2 2024 Jul 16, 2024	BUY	$120.0 - $182.95 $12,720 - $19,392	106 Added 3.73%	2,949 $371,000
Q1 2024 Apr 18, 2024	SELL	$170.78 - $208.42 $341,560 - $416,840	-2,000 Reduced 41.3%	2,843 $522,000
Q4 2023 Jan 08, 2024	BUY	$114.17 - $185.35 $63,021 - $102,313	552 Added 12.86%	4,843 $870,000
Q3 2023 Nov 17, 2023	BUY	$138.78 - $176.51 $155,849 - $198,220	1,123 Added 35.45%	4,291 $682,000
Q2 2023 Jul 18, 2023	BUY	$138.42 - $180.31 $55,367 - $72,124	400 Added 14.45%	3,168 $448,000
Q1 2023 Apr 07, 2023	BUY	$154.26 - $198.1 $161,973 - $208,005	1,050 Added 61.12%	2,768 $466,000
Q4 2022 Jan 17, 2023	BUY	$162.42 - $220.56 $94,690 - $128,586	583 Added 51.37%	1,718 $291,000
Q3 2022 Oct 14, 2022	BUY	$160.42 - $256.21 $182,076 - $290,798	1,135 New	1,135 $212,000

Others Institutions Holding RGEN

# of Institutions

524

Shares Held

58.9M

Call Options Held

323K

Put Options Held

667K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.46B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.

Account

Diversified Trust CO Repligen Corp Transaction History